Home » Topics » Medical technology

Medical technology
RSS

Other News To Note

Nov. 1, 2000

Uroghne Enters Research Deal, Closes Its First Funding Round

Nov. 1, 2000

Genelabs Presents Phase III Data Of Lupus Drug, Awaits FDA Action

Nov. 1, 2000

Galileo Raises $31M To Fund Diabetes, Nutritional Programs

Nov. 1, 2000

Product briefs: AVE neurovascular stent wins CE mark

Nov. 1, 2000

Fallout From Cantab Setback Continues With CEO Departure

Nov. 1, 2000

European Scientists To Convene On Use Of Genomic Information

Nov. 1, 2000

Product Pipeline: AVE receives CE mark for neurovascular stent

Nov. 1, 2000

Business Developments: Siemens, Thoratec in two larger deals

Nov. 1, 2000

CAT, HGS Extend Collaboration To Develop Antibodies For BLyS

Nov. 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...